SRPT vs STEP · rev $1.90B vs rev $1.99B
Sarepta Therapeutics Inc (SRPT) versus Stepstone Group Inc (STEP) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Stepstone Group Inc (STEP) is a asset management company listed on NASDAQ.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
Latest reported STEP revenue for 2026-03-31 was $1.99B. Net income was -$535.8M. Revenue was up 69.7% from 2025-03-31 to 2026-03-31. STEP currently screens at market cap $5.78B.
SRPT currently screens at market cap $2.34B. STEP currently screens at market cap $5.78B.
Not investment advice. Open the SRPT and STEP stock pages for the full models.
Not investment advice.